Cargando…

Prevalence of SARS-CoV-2 in Pregnant Women Assessed by RT-PCR in Franconia, Germany: First Results of the SCENARIO Study (SARS-CoV-2 prEvalence in pregNAncy and at biRth In FrancOnia)

Purpose Detection of SARS-CoV-2-infected pregnant women admitted to maternity units during a pandemic is crucial. In addition to the fact that pregnancy is a risk factor for severe COVID-19 and that medical surveillance has to be adjusted in infected women and their offspring, knowledge about infect...

Descripción completa

Detalles Bibliográficos
Autores principales: Hein, Alexander, Kehl, Sven, Häberle, Lothar, Tiemann, Carsten, Peuker, Rebecca, Mereutanu, Denise, Stumpfe, Florian M., Faschingbauer, Florian, Meyer-Schlinkmann, Kirstin, Koch, Martin C., Kainer, Franz, Dammer, Ulf, Philipp, Hanna, Kladt, Carolin, Schrauder, Michael G., Weingärtler, Stefan, Hanf, Volker, Hartmann, Arndt, Rübner, Matthias, Schneider, Holm, Lelieveld, Jos, Beckmann, Matthias W., Wurmthaler, Lena A., Fasching, Peter A., Schneider, Michael O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837405/
https://www.ncbi.nlm.nih.gov/pubmed/35169390
http://dx.doi.org/10.1055/a-1727-9672
_version_ 1784649901918912512
author Hein, Alexander
Kehl, Sven
Häberle, Lothar
Tiemann, Carsten
Peuker, Rebecca
Mereutanu, Denise
Stumpfe, Florian M.
Faschingbauer, Florian
Meyer-Schlinkmann, Kirstin
Koch, Martin C.
Kainer, Franz
Dammer, Ulf
Philipp, Hanna
Kladt, Carolin
Schrauder, Michael G.
Weingärtler, Stefan
Hanf, Volker
Hartmann, Arndt
Rübner, Matthias
Schneider, Holm
Lelieveld, Jos
Beckmann, Matthias W.
Wurmthaler, Lena A.
Fasching, Peter A.
Schneider, Michael O.
author_facet Hein, Alexander
Kehl, Sven
Häberle, Lothar
Tiemann, Carsten
Peuker, Rebecca
Mereutanu, Denise
Stumpfe, Florian M.
Faschingbauer, Florian
Meyer-Schlinkmann, Kirstin
Koch, Martin C.
Kainer, Franz
Dammer, Ulf
Philipp, Hanna
Kladt, Carolin
Schrauder, Michael G.
Weingärtler, Stefan
Hanf, Volker
Hartmann, Arndt
Rübner, Matthias
Schneider, Holm
Lelieveld, Jos
Beckmann, Matthias W.
Wurmthaler, Lena A.
Fasching, Peter A.
Schneider, Michael O.
author_sort Hein, Alexander
collection PubMed
description Purpose Detection of SARS-CoV-2-infected pregnant women admitted to maternity units during a pandemic is crucial. In addition to the fact that pregnancy is a risk factor for severe COVID-19 and that medical surveillance has to be adjusted in infected women and their offspring, knowledge about infection status can provide the opportunity to protect other patients and healthcare workers against virus transmission. The aim of this prospective observational study was to determine the prevalence of SARS-CoV-2 infection among pregnant women in the hospital setting. Material and Methods All eligible pregnant women admitted to the nine participating hospitals in Franconia, Germany, from 2 June 2020 to 24 January 2021 were included. COVID-19-related symptoms, secondary diseases and pregnancy abnormalities were documented. SARS-CoV-2 RNA was detected by RT-PCR from nasopharyngeal swabs. The prevalence of acute SARS-CoV-2 infection was estimated by correcting the positive rate using the Rogan–Gladen method. The risk of infection for healthcare workers during delivery was estimated using a risk calculator. Results Of 2414 recruited pregnant women, six were newly diagnosed RT-PCR positive for SARS-CoV-2, which yielded a prevalence of SARS-CoV-2 infection of 0.26% (95% CI, 0.10 – 0.57%). Combining active room ventilation and wearing FFP2 masks showed an estimated reduction of risk of infection for healthcare workers in the delivery room to < 1%. Conclusions The prevalence of newly diagnosed SARS-CoV-2 infection during pregnancy in this study is low. Nevertheless, a systematic screening in maternity units during pandemic situations is important to adjust hygienic and medical management. An adequate hygienic setting can minimise the calculated infection risk for medical healthcare workers during patientsʼ labour.
format Online
Article
Text
id pubmed-8837405
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Georg Thieme Verlag KG
record_format MEDLINE/PubMed
spelling pubmed-88374052022-02-14 Prevalence of SARS-CoV-2 in Pregnant Women Assessed by RT-PCR in Franconia, Germany: First Results of the SCENARIO Study (SARS-CoV-2 prEvalence in pregNAncy and at biRth In FrancOnia) Hein, Alexander Kehl, Sven Häberle, Lothar Tiemann, Carsten Peuker, Rebecca Mereutanu, Denise Stumpfe, Florian M. Faschingbauer, Florian Meyer-Schlinkmann, Kirstin Koch, Martin C. Kainer, Franz Dammer, Ulf Philipp, Hanna Kladt, Carolin Schrauder, Michael G. Weingärtler, Stefan Hanf, Volker Hartmann, Arndt Rübner, Matthias Schneider, Holm Lelieveld, Jos Beckmann, Matthias W. Wurmthaler, Lena A. Fasching, Peter A. Schneider, Michael O. Geburtshilfe Frauenheilkd Purpose Detection of SARS-CoV-2-infected pregnant women admitted to maternity units during a pandemic is crucial. In addition to the fact that pregnancy is a risk factor for severe COVID-19 and that medical surveillance has to be adjusted in infected women and their offspring, knowledge about infection status can provide the opportunity to protect other patients and healthcare workers against virus transmission. The aim of this prospective observational study was to determine the prevalence of SARS-CoV-2 infection among pregnant women in the hospital setting. Material and Methods All eligible pregnant women admitted to the nine participating hospitals in Franconia, Germany, from 2 June 2020 to 24 January 2021 were included. COVID-19-related symptoms, secondary diseases and pregnancy abnormalities were documented. SARS-CoV-2 RNA was detected by RT-PCR from nasopharyngeal swabs. The prevalence of acute SARS-CoV-2 infection was estimated by correcting the positive rate using the Rogan–Gladen method. The risk of infection for healthcare workers during delivery was estimated using a risk calculator. Results Of 2414 recruited pregnant women, six were newly diagnosed RT-PCR positive for SARS-CoV-2, which yielded a prevalence of SARS-CoV-2 infection of 0.26% (95% CI, 0.10 – 0.57%). Combining active room ventilation and wearing FFP2 masks showed an estimated reduction of risk of infection for healthcare workers in the delivery room to < 1%. Conclusions The prevalence of newly diagnosed SARS-CoV-2 infection during pregnancy in this study is low. Nevertheless, a systematic screening in maternity units during pandemic situations is important to adjust hygienic and medical management. An adequate hygienic setting can minimise the calculated infection risk for medical healthcare workers during patientsʼ labour. Georg Thieme Verlag KG 2022-02-11 /pmc/articles/PMC8837405/ /pubmed/35169390 http://dx.doi.org/10.1055/a-1727-9672 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.
spellingShingle Hein, Alexander
Kehl, Sven
Häberle, Lothar
Tiemann, Carsten
Peuker, Rebecca
Mereutanu, Denise
Stumpfe, Florian M.
Faschingbauer, Florian
Meyer-Schlinkmann, Kirstin
Koch, Martin C.
Kainer, Franz
Dammer, Ulf
Philipp, Hanna
Kladt, Carolin
Schrauder, Michael G.
Weingärtler, Stefan
Hanf, Volker
Hartmann, Arndt
Rübner, Matthias
Schneider, Holm
Lelieveld, Jos
Beckmann, Matthias W.
Wurmthaler, Lena A.
Fasching, Peter A.
Schneider, Michael O.
Prevalence of SARS-CoV-2 in Pregnant Women Assessed by RT-PCR in Franconia, Germany: First Results of the SCENARIO Study (SARS-CoV-2 prEvalence in pregNAncy and at biRth In FrancOnia)
title Prevalence of SARS-CoV-2 in Pregnant Women Assessed by RT-PCR in Franconia, Germany: First Results of the SCENARIO Study (SARS-CoV-2 prEvalence in pregNAncy and at biRth In FrancOnia)
title_full Prevalence of SARS-CoV-2 in Pregnant Women Assessed by RT-PCR in Franconia, Germany: First Results of the SCENARIO Study (SARS-CoV-2 prEvalence in pregNAncy and at biRth In FrancOnia)
title_fullStr Prevalence of SARS-CoV-2 in Pregnant Women Assessed by RT-PCR in Franconia, Germany: First Results of the SCENARIO Study (SARS-CoV-2 prEvalence in pregNAncy and at biRth In FrancOnia)
title_full_unstemmed Prevalence of SARS-CoV-2 in Pregnant Women Assessed by RT-PCR in Franconia, Germany: First Results of the SCENARIO Study (SARS-CoV-2 prEvalence in pregNAncy and at biRth In FrancOnia)
title_short Prevalence of SARS-CoV-2 in Pregnant Women Assessed by RT-PCR in Franconia, Germany: First Results of the SCENARIO Study (SARS-CoV-2 prEvalence in pregNAncy and at biRth In FrancOnia)
title_sort prevalence of sars-cov-2 in pregnant women assessed by rt-pcr in franconia, germany: first results of the scenario study (sars-cov-2 prevalence in pregnancy and at birth in franconia)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837405/
https://www.ncbi.nlm.nih.gov/pubmed/35169390
http://dx.doi.org/10.1055/a-1727-9672
work_keys_str_mv AT heinalexander prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia
AT kehlsven prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia
AT haberlelothar prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia
AT tiemanncarsten prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia
AT peukerrebecca prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia
AT mereutanudenise prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia
AT stumpfeflorianm prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia
AT faschingbauerflorian prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia
AT meyerschlinkmannkirstin prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia
AT kochmartinc prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia
AT kainerfranz prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia
AT dammerulf prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia
AT philipphanna prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia
AT kladtcarolin prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia
AT schraudermichaelg prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia
AT weingartlerstefan prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia
AT hanfvolker prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia
AT hartmannarndt prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia
AT rubnermatthias prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia
AT schneiderholm prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia
AT lelieveldjos prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia
AT beckmannmatthiasw prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia
AT wurmthalerlenaa prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia
AT faschingpetera prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia
AT schneidermichaelo prevalenceofsarscov2inpregnantwomenassessedbyrtpcrinfranconiagermanyfirstresultsofthescenariostudysarscov2prevalenceinpregnancyandatbirthinfranconia